Xaira Therapeutics
Xaira Therapeutics57
About
What does Xaira Therapeutics do?
Xaira Therapeutics is an AI-powered biotechnology company pioneering transformative artificial intelligence to discover and develop next-generation medicines. Their core product, X-Cell, is a virtual cell model and the largest causal perturbation model built to date, designed to accurately predict the outcomes of genetic perturbations. This technology aims to transform drug discovery into a predictive engineering discipline, ultimately delivering a pipeline of new medicines to patients.
What is Xaira Therapeutics's valuation?
StartupHub estimates Xaira Therapeutics's effective valuation at $2.8B (range $2.0B to $3.6B, 41% confidence), based on comparable companies in the sector.
Where is Xaira Therapeutics headquartered?
Xaira Therapeutics is headquartered in San Francisco, United States.
When was Xaira Therapeutics founded?
Xaira Therapeutics was founded in 2024.
What industry does Xaira Therapeutics operate in?
Xaira Therapeutics operates in Biotech, Drug Discovery, AI-Driven Protein Design, Genomics, MedTech, AI Infrastructure.
Ship of Theseus is developing a fleet of biologics based on the homeobox (HOX) family of transcription factors to create novel pharmaceuticals.
An independent research reference providing accessible, accurate, and transparent information on bioactive peptides and peptide science.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Leading AI agency in Guwahati specializing in biological intelligence, generative AI, and regulatory systems for Asia's underrepresented populations.
Spearmint Resources Inc. is a Canadian mineral exploration company focused on lithium, gold, and antimony projects.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
Feef is a voice-native AI agent that designs personalized fitness, nutrition, supplement, and recovery protocols, integrating them directly into your calendar.
Longevity and metabolic health platform offering personalized insights and interventions.
An entrant is a company tagged Biotech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 3 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.